Thermo Fisher Scientific Opens new Facility and Demonstration Laboratory in Switzerland
News Oct 22, 2008
Thermo Fisher Scientific Inc. has announced the opening of a new facility in Reinach, Switzerland, near Basel, to support the large pharmaceutical and chemical industry cluster in Switzerland near the French and German borders.
The facility houses Thermo Fisher’s analytical instrument operations and consolidates the Flux Instruments and Spectronex product lines that were acquired from SwissAnalytic Group.
Formally opened in September 2008, the new 12,000-square-foot facility features a 3,200 square foot demonstration laboratory containing new Thermo Scientific mass spectrometers and other laboratory instruments and consumables. There, customers will have the ability to work closely with the company’s technical experts to gain hands-on experience with new instrumentation. The facility also houses recently relocated commercial operations for the Fisher Scientific sales channel.
“With this new facility, we have finalized the integration of the former Flux Instruments and Spectronex businesses,” said Günter Wagner, general manager, Central Europe Sales, Thermo Fisher Scientific. “The new infrastructure and demonstration lab allows us to offer our customers more comprehensive support and further strengthens our position in Europe.”
The new facility was officially opened by Marc Casper, chief operating officer, Thermo Fisher Scientific. The ceremony included presentations by industry leaders including Professor Wolfram Weckwert of University of Vienna, Professor Gerald Haug of Swiss Federal Institute of Technology in Zurich and Dr Alexander Makarov of Thermo Fisher Scientific.
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Comet "Chury's" Late BirthNews
Comets which consist of two parts, like Chury, can form after a catastrophic collision of larger bodies. Such collisions may have taken place in a later phase of our solar system, which suggests that Chury can be much younger than previously assumed. This is shown through computer simulations.READ MORE
Nanotechnology Detects Molecular Biomarker for OsteoarthritisNews
For the first time, scientists have been able to measure a specific molecule indicative of osteoarthritis and a number of other inflammatory diseases using a newly developed technology. This preclinical study used a solid-state nanopore sensor as a tool for the analysis of hyaluronic acid.READ MORE